Lunit acquires NZ-based AI diagnostics firm Volpara
Hyun-Ah Oh
Dec 14, 2023 (Gmt+09:00)
South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Volpara Health Technologies for $193.07 million.
Under the deal, Volpara is valued at AUD 1.15 per share. This is a 47.4% increase from its previous closing price on the Australian Securities Exchange.
Lunit aims to finance this acquisition through external borrowings and expects the merger process to be complete within the next 3-6 months.
Dec 01, 2023 (Gmt+09:00)
Nov 14, 2023 (Gmt+09:00)
Nov 10, 2023 (Gmt+09:00)
Jul 26, 2023 (Gmt+09:00)
Apr 04, 2023 (Gmt+09:00)